Cargando…
Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy
Autores principales: | Piaserico, Stefano, Gisondi, Paolo, Cazzaniga, Simone, Naldi, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433672/ https://www.ncbi.nlm.nih.gov/pubmed/32812188 http://dx.doi.org/10.1007/s40257-020-00552-w |
Ejemplares similares
-
Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence
por: Piaserico, Stefano, et al.
Publicado: (2022) -
Preference for Telemedicine Versus In-Person Visit Among Patients with Psoriasis Receiving Biological Drugs
por: Gisondi, Paolo, et al.
Publicado: (2021) -
Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
por: Gisondi, Paolo, et al.
Publicado: (2021) -
Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review
por: Gisondi, Paolo, et al.
Publicado: (2021) -
Could Targeted Pharmacotherapies Exert a “Disease Modification Effect” in Patients with Chronic Plaque Psoriasis?
por: Bellinato, Francesco, et al.
Publicado: (2022)